Aprea Therapeutics Inc Share Price

NASDAQ: APRE

Small Cap

$1.55

-0.02

(-1.27%)

as on September 13, 2025 at 1:29 am IST

$₹

Aprea Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's High
$1.55
Day's Price Range
$1.6
$1.55
3.23%
Upside
52 Week's Low
52 Week's High
$1.41
52-Week Price Range
$5.01
$1.55
8.90%
Downside
223.23%
Upside

Aprea Therapeutics Inc share price movements today

Previous Close: $1.57
Open: $1.60
Volume: 379.6K
Day's Low - High: $1.55 - $1.6
52 Week Low - High: $1.41 - $5.01

Aprea Therapeutics Inc Historical Returns

1 Month Return: -9.71 %
3 Month Return: -16.09 %
1 Year Return: -50.99 %
3 Year Return: -91.7 %
5 Year Return: -99.71 %

Aprea Therapeutics Inc Stock Fundamentals & Key Indicators

Check Aprea Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.1M

EPS (TTM)

-0.67

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-14.8M

Revenue (TTM)

841.0K

Profit Margin

0.00%

Return On Equity TTM

27266200.00%

Aprea Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aprea Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aprea Therapeutics Inc	BUY	$9.1M	-99.71%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Aprea Therapeutics Inc Stock including INR - Dollar returns

The Aprea Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Aprea Therapeutics Inc investment value today

Current value as on today

₹54,345

Returns

₹45,655

(-45.65%)

Returns from Aprea Therapeutics Inc Stock

₹50,794 (-50.79%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Aprea Therapeutics Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Aprea Therapeutics Inc. Average target price of $10.5

Aprea Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Aprea Therapeutics Inc.

What analysts predicted

85.24%UPSIDE

Target Price

$10.5

Current Price

$1.55

Analyzed by

9 Analysts

Target

$10.50

Aprea Therapeutics Inc target price $10.5, a slight upside of 85.24% compared to current price of $1.55. According to 9 analysts rating.

Aprea Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Aprea Therapeutics Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-63% versus previous 30 day period

Aprea Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	0	0	0	0	0	0	0	-	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-4	-3	-3	-3	-3	-3	-4	-3	-4	-3
EBITDA	-4	-3	-3	-3	-3	-3	-4	-3	-4	-3
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-3	-3	-3	-2	-3	-3	-2	-3	-3
Income Tax Expense	0	0	0	0	0	0	-	0	-	-
Net Income	-4	-3	-3	-3	-2	-3	-3	-2	-3	-3
Net Profit Margin	0.00%	-1305.27%	-1003.08%	-24463.62%	-738.39%	-617.92%	-1066.99%	-1406.49%	0.00%	-2742.23%

Aprea Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2012	Dec 2013	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	0	1
Gross Profit	-	-	0	0	0	0	0	0	0	1
Operating Income	0	0	-15	-16	-31	-52	-37	-37	-15	-14
EBITDA	-	-	-15	-15	-27	-53	-36	-112	-14	-12
Interest Expense	-	-	0	0	0	0	0	0	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	0	0	-15	-15	-28	-53	-37	-112	-14	-12
Income Tax Expense	-	-	0	0	-1	0	0	112	0	-
Net Income	0	0	-15	-15	-26	-53	-36	-224	-14	-12
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2449.59%	-862.43%

Aprea Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-3	-3	-2	-3	-3	-2	-3	-3
Operating Cash Flow	-3	-2	-3	-3	-3	-2	-3	-3	-3
Investing Cash Flow	0	0	0	0	0	0	0	-	-
Financing Cash Flow	0	0	0	14	0	0	0	0	0
Change in Cash	-3	-2	-3	10	-3	-2	-3	-3	-2

Aprea Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2013	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	0	-15	-15	-28	-53	-37	-112	-14	-12
Operating Cash Flow	-	-14	-15	-26	-41	-37	-25	-12	-13
Investing Cash Flow	-	0	0	0	0	-	-	0	0
Financing Cash Flow	-	23	56	92	0	1	0	5	14
Change in Cash	-	10	41	64	-41	-35	-24	-7	1

Global Institutional Holdings in Aprea Therapeutics Inc

Funds	Holdings
AIGH Capital Management, LLC	9.75%
Sio Capital Management, LLC	5%
Sphera Funds Management Ltd.	4.88%
Nantahala Capital Management, LLC	3.72%
Vanguard Group Inc	3.14%

See all

Insights on Aprea Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 126.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 214.7%
NEGATIVE IMPACT
Price Dip
In the last 6 months, APRE stock has moved down by -35.4%

About Aprea Therapeutics Inc

annan naturvetenskaplig och teknisk forskning och utveckling

Organisation	Aprea Therapeutics Inc
Headquarters	3805 Old Easton Road, Doylestown, PA, United States, 18902
Industry	Commercial Services
CEO	Dr. Oren Gilad Ph.D.
E-voting on shares	Click here to vote

Key Management of Aprea Therapeutics Inc

Name	Title
Dr. Lars B. Abrahmsen Ph.D.	Senior VP & Chief Scientific Officer
Mr. Brian Wiley	Senior Vice President of Corporate Development & Strategy
Dr. Michel Afargan Ph.D.	Head of Pharmacology Development
Mr. Ze'ev Weiss B.Sc., C.P.A.	Chief Business Advisor
Ms. Andrea Epstein	Controller
Dr. Oren Gilad Ph.D.	Co-Founder, CEO, President & Director
Mr. John P. Hamill CPA	Senior VP, CFO, Principal Accounting Officer & Secretary

FAQs

What is Aprea Therapeutics Inc share price today?

Aprea Therapeutics Inc share price today is $1.55 as on September 13, 2025 at 1:29 am IST at the close of the market. Aprea Therapeutics Inc share today touched a day high of $1.6 and a low of $1.55.

What is the 52 week high and 52 week low for Aprea Therapeutics Inc share?

Aprea Therapeutics Inc share touched a 52 week high of $5.01 on October 18, 2024 and a 52 week low of $1.41 on April 21, 2025. Aprea Therapeutics Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $1.55,which is 69.06% down from its 52 week high and 9.77% up from its 52 week low.

What is Aprea Therapeutics Inc's market capitalisation today?

Aprea Therapeutics Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Aprea Therapeutics Inc Stock (APRE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aprea Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aprea Therapeutics Inc Shares that will get you 0.9677 shares as per Aprea Therapeutics Inc share price of $1.55 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aprea Therapeutics Inc Stock (APRE) from India?

Indian investors can start investing in Aprea Therapeutics Inc (APRE) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Aprea Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 10:43 am IST). Based on Aprea Therapeutics Inc share’s latest price of $1.55 as on September 13, 2025 at 1:29 am IST, you will get 6.4516 shares of Aprea Therapeutics Inc. Learn more about fractional shares .

What are the returns that Aprea Therapeutics Inc has given to Indian investors in the last 5 years?

Aprea Therapeutics Inc stock has given -99.71% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?